BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17377037)

  • 1. Fat-containing nodules in the cirrhotic liver: chemical shift MRI features and clinical implications.
    Yu JS; Chung JJ; Kim JH; Kim KW
    AJR Am J Roentgenol; 2007 Apr; 188(4):1009-16. PubMed ID: 17377037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small hyperintense hepatic lesions on T1-weighted images in patients with cirrhosis: evaluation with serial MRI and imaging features for clinical benignity.
    Shimizu A; Ito K; Sasaki K; Hayashida M; Tanabe M; Shimizu K; Matsunaga N
    Magn Reson Imaging; 2007 Dec; 25(10):1430-6. PubMed ID: 17524587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperintense nodules on non-enhanced T1-weighted gradient-echo magnetic resonance imaging of cirrhotic liver: fate and clinical implications.
    Yu JS; Lee JH; Park MS; Kim KW
    J Magn Reson Imaging; 2006 Sep; 24(3):630-6. PubMed ID: 16888794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nondysplastic nodules that are hyperintense on T1-weighted gradient-echo MR imaging: frequency in cirrhotic patients undergoing transplantation.
    Krinsky GA; Israel G
    AJR Am J Roentgenol; 2003 Apr; 180(4):1023-7. PubMed ID: 12646448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications.
    Jeong YY; Mitchell DG; Kamishima T
    AJR Am J Roentgenol; 2002 Jun; 178(6):1327-34. PubMed ID: 12034592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-hypervascular hypointense nodules ≥1 cm on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging in cirrhotic livers.
    Yoon JH; Lee JM; Yang HK; Lee KB; Jang JJ; Han JK; Choi BI
    Dig Dis; 2014; 32(6):678-89. PubMed ID: 25376284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.
    Earls JP; Theise ND; Weinreb JC; DeCorato DR; Krinsky GA; Rofsky NM; Mizrachi H; Teperman LW
    Radiology; 1996 Oct; 201(1):207-14. PubMed ID: 8816545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large (>or=2 cm) non-hypervascular nodules depicted on MRI in the cirrhotic liver: fate and implications.
    Yu JS; Chung JJ; Kim JH; Kim KW
    Clin Radiol; 2008 Oct; 63(10):1121-30. PubMed ID: 18774359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration.
    Golfieri R; Grazioli L; Orlando E; Dormi A; Lucidi V; Corcioni B; Dettori E; Romanini L; Renzulli M
    J Magn Reson Imaging; 2012 Sep; 36(3):648-57. PubMed ID: 22592930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
    Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
    Clin Imaging; 2008; 32(6):453-9. PubMed ID: 19006774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE; Kim SH; Lee SJ; Rhim H
    AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperechoic liver nodules: characterization with proton fat-water chemical shift MR imaging.
    Martín J; Puig J; Falcó J; Donoso L; Rué M; Sentís M; Darnell A; Musulén E
    Radiology; 1998 May; 207(2):325-30. PubMed ID: 9577476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
    Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW
    AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of hepatic masses: diagnostic significance of wedge-shaped areas of increased signal intensity surrounding the lesion.
    Giovagnoni A; Terilli F; Ercolani P; Paci E; Piga A
    AJR Am J Roentgenol; 1994 Nov; 163(5):1093-7. PubMed ID: 7976881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver.
    Le Moigne F; Durieux M; Bancel B; Boublay N; Boussel L; Ducerf C; Berthezène Y; Rode A
    Magn Reson Imaging; 2012 Jun; 30(5):656-65. PubMed ID: 22459435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.